Log in to save to my catalogue

Formulation and Evaluation of Venlafaxine Hydrochloride Niosomes

Formulation and Evaluation of Venlafaxine Hydrochloride Niosomes

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2277337033

Formulation and Evaluation of Venlafaxine Hydrochloride Niosomes

About this item

Full title

Formulation and Evaluation of Venlafaxine Hydrochloride Niosomes

Publisher

Karad: Human Journals

Journal title

Journal of Current Pharma Research, 2018-05, Vol.8 (3), p.2393-2402

Language

English

Formats

Publication information

Publisher

Karad: Human Journals

More information

Scope and Contents

Contents

The aim of this study was to formulate and evaluate niosomes of venlafaxine HCl. It is a selective serotonin reuptake inhibitor type of drug used in the treatment of depression. It is practically soluble in water belongs to BCS class I with a bioavailability approximately 45%. Niosomes of venlafaxine HCl were prepared by using the cholesterol and s...

Alternative Titles

Full title

Formulation and Evaluation of Venlafaxine Hydrochloride Niosomes

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2277337033

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2277337033

Other Identifiers

ISSN

2230-7834

E-ISSN

2230-7842

DOI

10.33786/JCPR.2018.v08i03.002

How to access this item